San Carlos, CA
Summary
This company is focused on developing senoblockers, a novel class of therapeutics aimed at rejuvenating cells and tissues to address age-associated diseases. Their approach is based on patented technology from Stanford University, targeting the biological mechanisms of aging to enhance regenerative capacity and combat the accumulation of senescent cells.
Based on content on doriantherapeutics.com
No similar companies found
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
4.0 years — Since Jan 2021
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
325414
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Biotechnology and Pharmaceuticals
2. Biological Product (except Diagnostic) Manufacturing
No vendors identified.
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|